基于制度移植视角对我国孤儿药管理制度构建研究

发布时间：2018-04-30 21:21

  本文选题：制度移植 + 孤儿药管理制度　； 参考：《中国卫生事业管理》2017年07期

【摘要】：目的:构建符合我国国情的孤儿药管理制度,促进孤儿药的生产与供给。方法:基于制度移植理论,运用文献研究法对美国、欧盟、日本的孤儿药管理制度的主要内容和制度特色进行比较和分析。结果:在孤儿药的管理上,美国、欧盟和日本在制度设计中均涉及诸多激励措施,给孤儿药的研发和上市带来积极影响。结论:推动制度供给外生变量,制定孤儿药管理的法律法规,成立孤儿药认证和管理机构,完善医保制度等配套制度。
[Abstract]:Objective: to construct the management system of orphan drugs in China to promote the production and supply of orphan drugs. Methods: based on the theory of institutional transplantation, the main contents and characteristics of Orphan Drug Administration system in USA, EU and Japan were compared and analyzed by literature research. Results: in the management of orphan drugs, the United States, the European Union and Japan all involved many incentives in the system design, which had a positive impact on the development and marketing of orphan drugs. Conclusion: promote the system to supply exogenous variables, formulate the laws and regulations of Orphan Drug Management, set up Orphan Drug Certification and Management Organization, perfect the medical insurance system and other supporting systems.
【作者单位】： 南京中医药大学卫生经济管理学院;
【基金】：教育部哲学社会科学研究重大课题攻关项目”基本医疗服务保障法制化研究”(编号:14JZD025)
【分类号】：R951
，

本文编号：1826285